Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Microsoft PowerPoint - Roche IR Event EULAR Final.ppt
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Rituximab: A novel biological agent for rheumatoid<br />
arthritis<br />
• Rituximab (RTX) is a novel<br />
genetically engineered<br />
anti-CD20 therapeutic<br />
monoclonal antibody that<br />
selectively targets<br />
CD20+ B cells<br />
Shaw et al. Ann Rheum Dis 2003;62(Suppl. 2):55–59; Silverman & Weisman. Arthritis Rheum 2003;48:1484–1492<br />
31